2015
DOI: 10.1016/j.ijpharm.2015.09.008
|View full text |Cite
|
Sign up to set email alerts
|

Delivery of tissue plasminogen activator and streptokinase magnetic nanoparticles to target vascular diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
25
0
2

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 47 publications
(27 citation statements)
references
References 23 publications
0
25
0
2
Order By: Relevance
“…Plants produce phenolic compounds which have significant antioxidant properties . The TP content of MC films with and without incorporated NCS containing EO was measured.…”
Section: Resultsmentioning
confidence: 99%
“…Plants produce phenolic compounds which have significant antioxidant properties . The TP content of MC films with and without incorporated NCS containing EO was measured.…”
Section: Resultsmentioning
confidence: 99%
“…As in other fibrinolytic particles discussed previously, encapsulating or immobilizing PA on MNP increases enzyme stability during storage and improves half‐life . Magnetic nanoparticles carrying tPA, uPA, or SK have been decorated with coatings that further improve half‐life and reduce immunogenicity including dextran, chitosan, silica, hydrosol, PLGA and PLA‐PEG, polyacrylic acid (PAA), PEG, poly[aniline‐co‐N‐(1‐one‐butyric acid) aniline], and heparin . Plasminogen activator functionalization of MNP can rely on either physical adsorption to the MNP matrix or covalent attachment .…”
Section: Magnetic Particles and Magnetic Field Controlmentioning
confidence: 99%
“…The simplest form of magnetic control is to use a permanent magnet to establish a magnetic field gradient to move MNP toward a target (Figure A, Table ). This is the most widely reported method for manipulating PA carriers . Ma et al.…”
Section: Magnetic Particles and Magnetic Field Controlmentioning
confidence: 99%
See 1 more Smart Citation
“…Delivery of drugs other than chemotherapeutic agents is possible, too. 24 In addition, the endoscopic magnetotargeted delivery can be combined with immunologicaltargeted delivery by linking with tumor-specific antibodies. 25 Hereby, the SPION may first be guided to the tumor site with magnetic forces and thereafter target even more specifically only a certain cell type in the tumor microenvironment.…”
Section: Biophysical Model and Simulationsmentioning
confidence: 99%